Marked rise in BP.
Adrenaline should not be given to patients receiving β blockers.
Source: KDT 7e · p133
Beta Blocker · Antihypertensive
Pindolol is a beta-adrenoceptor blocker that possesses intrinsic sympathomimetic activity (partial agonist activity). It stimulates as well as blocks adrenergic receptors. This allows it to prevent overstimulation of the heart by endogenous catecholamines while assuring slight receptor stimulation in patients sensitive to negative inotropic and chronotropic effects of beta blockade.
Marked rise in BP.
Adrenaline should not be given to patients receiving β blockers.
Source: KDT 7e · p133
Hyperkalaemia more likely.
Source: KDT 7e
Severe bradycardia.
Extreme caution advised if amiodarone is co-administered with sofosbuvir and a beta blocker.
Source: Harrison 22e · unknown
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Increased propensity for AV block, severe bradycardia, and decreased left ventricular function.
Avoid concurrent administration. The concurrent administration of diltiazem with a beta blocker is contraindicated.
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team